EAM Investors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

EAM Investors’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-110,986	Closed	-$3.7M	–	369
2024 Q3	$3.7M	Buy	110,986 +85,456	+335%	+$2.94M	0.55%	94
2024 Q2	$690K	Sell	25,530 -131,035	-84%	-$2.58M	0.11%	205
2024 Q1	$3.38M	Buy	+156,565	New	+$3.41M	0.53%	106

EAM Investors's LBPH Position: Q4 2024 in Review

EAM Investors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 110,986 shares — an estimated $3.7M sold.

EAM Investors first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $3.7M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

EAM Investors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
EAM Investors sold 110,986 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $3.7M.
EAM Investors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
EAM Investors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $3.7M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.